NCT03271138 - Bifidobacterium Infantis NLS Super Strain for Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

December 7, 2017

Conditions

Celiac Disease

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium infantis NLS super strain (Natren LIFE START®2)

2 capsules, 3 times per day, for daily total of 12x10\^9 CFU Bifidobacterium infantis NLS super strain

OTHER

Placebo

2 capsules, 3 times per day, containing rice flour, hydroxypropyl and methylcellulose

Trial Locations (1)

Small Bowel Section, Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires

All Listed Sponsors

collaborator

Dr. C. Bonorino Udaondo Gastroenterology Hospital

OTHER_GOV

collaborator

Research Institute, Universidad del Salvador

UNKNOWN

collaborator

Consejo de Investigaciones en Salud, Ministerio de Salud, Gobierno Autónomo de Buenos Aires

UNKNOWN

lead

Global Institute of Probiotics

OTHER